BGM
BGM
NASDAQ · Pharmaceuticals

Bgm Group Ltd

$0.30
+0.00 (+1.45%)
As of Aug 8, 10:33 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.44B
Net Income
-82,731,621
Gross Margin
16.4%
Profit Margin
-5.8%
Rev Growth
-24.0%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 16.4% 16.4% 33.1% 33.1%
Operating Margin -2.2% -2.0% 16.8% 14.4%
Profit Margin -5.8% -5.5% 11.7% 12.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.44B 1.89B 106.35M 109.96M
Gross Profit 235.82M 310.17M 35.22M 36.42M
Operating Income -32,373,769 -38,322,230 17.84M 15.80M
Net Income -82,731,621 -97,932,998 12.42M 13.50M
Gross Margin 16.4% 16.4% 33.1% 33.1%
Operating Margin -2.2% -2.0% 16.8% 14.4%
Profit Margin -5.8% -5.5% 11.7% 12.3%
Rev Growth -24.0% -24.0% +7.5% +6.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 23.86M 26.94M
Total Equity 126.32M 122.05M
D/E Ratio 0.19 0.22
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 38.61M 48.24M 22.69M 21.79M
Free Cash Flow 8.29M 10.61M